Eligibility, any sex, with Cochlear Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Freiburger Monosyllabic Word Recognition Score in QuietPrimary· The Freiburger monosyllabic word test is performed 12 months after device activation
Percent correct in the Freiburger Monosyllabic Word test
Group
Value
95% CI
EAS CI Users
50.6
± 23.8
Hochmair-Desoyer Schultz and Moser (HSM) Sentence Score or Oldenburger Sentence Test (OlSa) Recognition Score in QuietSecondary· The test (HSM or OlSa) is performed 12 months after device activation
Percent correct in either the HSM sentence test or the Oldenburger sentence test (score from 0 to 100%)
Group
Value
95% CI
EAS CI Users
75.6
± 22.7
Sponsor's own description
This is a retrospective study designed to collect long-term speech perception results for cochlear implants recipients using electro-acoustic-stimulation as measured in the clinical routine and to confirm the performance of sound processors associated with acoustic earhooks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07509788 — Effects of Binaural Hearing on Listening Effort and Cognitive Development in Mandarin-speaking Children With Cochlear Im
· recruiting
NCT07068373 — Development of Evidence-based Therapeutic Guidelines for Early SLA in Urdu-speaking Children With Cochlear Implants
· active not recruiting
NCT06960616 — Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
· NA
· recruiting
NCT05486637 — Vocal Emotion Communication With Cochlear Implants
· EARLY_PHASE1
· recruiting
Other Advanced Bionics AG trials
Trials by the same sponsor.
NCT06268340 — Hearing and Structure Preservation Via ECochG
· NA
· recruiting
NCT04815343 — Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios
· NA
· completed
NCT04610216 — Investigation of the Automatic Technology on the Naída M Hearing Devices
· completed
NCT04610112 — Safety and Performance of HiRes Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss
· completed
NCT03078920 — Benefits of a Contralateral Routing of Signals (CROS) System in Unilateral CI-recipients
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Advanced Bionics AG
Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06301568.